Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2092]

Interventional oncology accreditation programme IASIOS continues to reach new heights

Interventional oncology accreditation programme IASIOS continues to reach new heights

How to avoid heart damage in women receiving breast cancer treatment

How to avoid heart damage in women receiving breast cancer treatment

Are cannabis products safe and effective for reducing symptoms in children with cancer?

Are cannabis products safe and effective for reducing symptoms in children with cancer?

New resource to help families understand paediatric Hodgkin lymphoma

New resource to help families understand paediatric Hodgkin lymphoma

Journal review summarises latest research on gamma delta T cells for tumour immunotherapy

Journal review summarises latest research on gamma delta T cells for tumour immunotherapy

Cancel cervical cancer – In conversation with Brazil, Colombia, and Uruguay experts

Cancel cervical cancer – In conversation with Brazil, Colombia, and Uruguay experts

Additional COVID-19 boosters can benefit cancer patients—how often they should get them depends on their treatment

Additional COVID-19 boosters can benefit cancer patients—how often they should get them depends on their treatment

Short-term use of immunosuppressants not linked to cancer risk

Short-term use of immunosuppressants not linked to cancer risk

European Commission approves reduced dosing frequency of teclistamab for multiple myeloma

European Commission approves reduced dosing frequency of teclistamab for multiple myeloma

Inhibition of prmt5 by repurposing market drugs - a fresh therapeutic pathway for cancer treatment

Inhibition of prmt5 by repurposing market drugs - a fresh therapeutic pathway for cancer treatment

More from ecancer